BridgeMD
New treatment option for Smoking Cessation
Official title Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization
ClinicalTrials.gov ID: NCT05672914
What this study is testing
- What it's testing
- Cigarette smoking is the leading cause of death and disability in the United States. People with psychiatric disorders consume almost half (44.3%) of all cigarettes smoked in the U.S.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female patients above the age of 18 capable of providing informed consent
- Current smoker (at least 5 cigarettes/day when not hospitalized)
- Willing and able to provide informed consent, attend all study visits, and comply with the protocol
You likely can't join if
- Mini-Mental State Examination (MMSE) score \< 24
- Current diagnosis of dementia or other cognitive impairment that would limit study participation
- Inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures
- Current diagnosis of a (non-nicotine) substance use disorder requiring detoxification
- No access to or inability to communicate by phone, or no stable mailing address
- Planned discharge to institutional care (e.g., nursing home, long-term rehabilitation, jail, etc.)
See the full eligibility criteria
- Male or female patients above the age of 18 capable of providing informed consent
- Current smoker (at least 5 cigarettes/day when not hospitalized)
- Willing and able to provide informed consent, attend all study visits, and comply with the protocol
- Mini-Mental State Examination (MMSE) score \< 24
- Current diagnosis of dementia or other cognitive impairment that would limit study participation
- Inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures
- Current diagnosis of a (non-nicotine) substance use disorder requiring detoxification
- No access to or inability to communicate by phone, or no stable mailing address
- Planned discharge to institutional care (e.g., nursing home, long-term rehabilitation, jail, etc.)
- Medical contraindication to nicotine patch use
- Currently pregnant or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Austin, Texas, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Austin, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.